M. M. ÖZBALAK Et Al. , "HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study," Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021) , vol.21, United States Of America, pp.368-369, 2021
ÖZBALAK, M. M. Et Al. 2021. HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study. Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021) , (United States Of America), 368-369.
ÖZBALAK, M. M., AKAY, O. M., PEHLİVAN, M., YILDIZ, B., UZAY, A., YİĞENOĞLU, T. N., ... ELVERDİ, T.(2021). HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study . Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021) (pp.368-369). , United States Of America
ÖZBALAK, MUSTAFA Et Al. "HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study," Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021), United States Of America, 2021
ÖZBALAK, MUSTAFA M. Et Al. "HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study." Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021) , United States Of America, pp.368-369, 2021
ÖZBALAK, M. M. Et Al. (2021) . "HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study." Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021) , United States Of America, pp.368-369.
@conferencepaper{conferencepaper, author={MUSTAFA MURAT ÖZBALAK Et Al. }, title={HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study}, congress name={Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021)}, city={}, country={United States Of America}, year={2021}, pages={368-369} }